NCT04646499View on ClinicalTrials.gov

Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

May 31, 2022

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

Transcranial alternating current stimulation

Transcranial alternating current stimulation (tACS) will be applied at 40 Hz (gamma band) during eight sessions over the course of a month.

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Francisco

OTHER

NCT04646499 - Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory | Biotech Hunter | Biotech Hunter